Today: 22/05/2022 02:27:41 (GMT+7)

Vietnam able to produce Covid-19 treatment drug molnupiravir

Three pharmaceutical companies in Vietnam are planning to or are producing molnupiravir pills to treat Covid-19 patients with mild or no symptoms, according to the Ministry of Health.

Of the three, the drug manufactured by Stellapharm Vietnam has been approved for clinical trial. Because molnupiravir has yet been granted with a circulation registration number in Vietnam, the Ministry of Health is considering asking the Government for approval of using the drug in emergency cases.

Vietnam, Covid-19 treatment drug, molnupiravir, mild or no symptoms,  pharmaceutical companies, emergency cases, Covid-19 pandemic

Molnupiravir pills.

If approved by the Government, it is expected that three registration numbers will be issued for three types of molnupiravir drugs manufactured by domestic pharmaceutical companies.

Regarding the effectiveness of molnupiravir on Covid-19 patients in Vietnam, the Department of Science, Technology and Training under the Ministry of Health said that from the end of August, the ministry has piloted using molnupiravir for non-hospitalised patients. Ho Chi Minh City was the first locality to implement this pilot programme. At present, it has been carried out in 34 provinces and cities.

The ministry has provided 110,000 doses, including 50,000 doses of molnupiravir 400 mg Stella VN, and 60,000 doses of molnupiravir 200 mg Optimus produced by India to localities.

The use of the drug in 22 provinces and cities show that molnupiravir is safe and well-accepted, and has obvious effectiveness in reducing viral load, virus spread and the number of severe cases, and shortening treatment time, with no fatalities recorded.

Molnupiravir is developed by the US-based pharmaceutical companies Ridgeback Biotherapeutics and Merck & Co., Inc.

Businesses advised to avoid basic mistakes when exporting farm produce to EU
Vietnamese enterprises should avoid basic mistakes when exporting food and agricultural products to the European Union (EU), heard a consultancy session for exports to Belgium and the EU which was held by the Vietnam Trade Promotion Agency under the Ministry of Industry and Trade on November 22.
JICA presents medical devices for Covid-19 treatment to Ho Chi Minh City
The Japan International Cooperation Agency (JICA) on July 30 announced that it will present some medical devices for Covid-19 treatment worth about JPY120 million (US$1.1 million) to Ho Chi Minh City.
Over 80 percent of Covid-19 patients recover, Bac Giang scales back treatment facilities
(BGO) – As of July 6, the health sector in Bac Giang province scaled back 6 Covid-19 treatment facilities, reported the provincial Health Department. 
Military set up two Covid-19 treatment hospitals in Bac Giang, Bac Ninh
The military are urgently setting up two temporary hospitals to provide care for Covid-19 patients in the northern provinces of Bac Ninh and Bac Giang, which are the two provinces affected the worst by the current Covid-19 resurgence in Vietnam, on May 19 afternoon.

Source: NDO/VNA

Vietnam, Covid-19 treatment drug, molnupiravir, mild or no symptoms, pharmaceutical companies, emergency cases, Covid-19 pandemic
New comment has just been added. Click here
Sort:NewBest News